Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0RMHEN
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
PRO-1107
|
|||||
| Synonyms |
PRO-1107; PRO 1107; PRO1107
Click to Show/Hide
|
|||||
| Organization |
ProfoundBio (Suzhou) Co., Ltd.
|
|||||
| Drug Status |
Phase 1/2
|
|||||
| Indication |
In total 6 Indication(s)
|
|||||
| Drug-to-Antibody Ratio |
8
|
|||||
| Antibody Name |
Undisclosed
|
|||||
| Antigen Name |
Inactive tyrosine-protein kinase 7 (PTK7)
|
Antigen Info | ||||
| Payload Name |
Monomethyl auristatin E
|
Payload Info | ||||
| Therapeutic Target |
Microtubule (MT)
|
Target Info | ||||
| Linker Name |
Undisclosed
|
|||||
| Conjugate Type |
Undisclosed
|
|||||
| Combination Type |
LD343
|
|||||
